$VNRX Q2 '26 Earnings Results & Recap VolitionRx Limited reported total revenues of $0.4 million for the three months ended June 30, 2026, and $1.4 million for the six months ended June 30, 2026, reflecting ongoing commercialization activities.
$VNRX Q2 '26 Earnings Results & Recap VolitionRx Limited reported total revenues of $0.4 million for the three months ended June 30, 2026, and $1.4 million for the six months ended June 30, 2026, reflecting ongoing commercialization activities.